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ABSTRACT
Background: 
. Severe disease can be fatal, 
although majority of cases are mild and self-limited.
Objective: To determine the prognostic 
factors for leptospirosis that associated with 
mortality in patients with leptospirosis in Dr. 
Sardjito General Hospital, Yogyakarta.
e conducted a retrospective 
study of data collected in our hospital between Jan 
2010 until May 2011, from whom the diagnosis of 
leptospirosis was confirmed based on pertinent 
clinical and epidemiological data and positive 
serology.
Result: Thirty two patients were included in 
this study, including 29 survivors (90.62%) and 3 
non-survivors (9.38%). Of these 32 patients, 26 
patients (81.25%) were admitted to the medical 
ward and 6 patients (18.75 %) were admitted to the 
ICU.  Multivariate logistic regression demonstrated 
that three factors were independently associated 
with mortality: higher level of potassium (OR 10.8; 
CI 1.194-97.728; p<0.01) on admission and 
neurological dysfunction (altered mentation or 
seizure) (OR 30; CI 4.367–206.07; p<0.01)
Conclusion: The mortality of leptospirosis 
remains high despite improvements in patients care. 
In order to improve the early treatment of high-risk 
patients, these higher levels of potassium on 
admission and neurological dysfunction, which are 
associated with mortality, can be used at the time of 
admission as prognostic factors.
Leptospirosis, an infectious 
disease that affects humans and animals, is a 
common zoonosis with a variety of clinical 
manifestations. Yogyakarta is one of the cities with a 
high incidence of leptospirosis. It is important to 
recognize the clinical features and prognostic 
factors of this disease
Methods: W
Keywords : Leptospirosis, prognostic factors, 
mortality
Background
Leptospirosis is the most widespread 
zoonosis with recent outbreaks in several Asian, 
1Central, and South American countries.  
Leptospirosis is a zoonotic disease, which is caused 
by Leptospira and transmitted to human by contact 
with Leptospira contaminated animal urine or 
Leptospira contaminated environment. Thirty-two 
patients with Leptospirosis had admitted in Dr. 
Sardjito General Hospital from January 2010 until 
2May 2011.  In Indonesia, the spread of leptospirosis 
is in the Province of West Java, Central Java, 
Yogyakarta, Lampung, South Sumatra, Bengkulu, 
Riau, West Sumatra, North Sumatra, Bali, NTB, 
South Sulawesi, North Sulawesi, East Kalimantan 
and West Kalimantan. The mortality rate of 
leptospirosis in Indonesia is high, reaching 2.5 to 
16.45%. At the age of over 50 years mortality rate 
can be up to 56%. When Leptospirosis patient is 
accompanied by a yellow lining of the eye indicating 
damage to liver tissue, the risk of death will be 
higher. Several publications reported mortality rates 
between 3% -54% depending on the infected organ 
3system.
We believe that early evaluation of disease 
severity at the time of admission might be useful in 
improving the care of patients with leptopsirosis.
Objective
The purpose of this study is to determine the 
prognostic factors for leptospirosis that associated 
with mortality in patients with leptospirosis at Dr. 
Sardjito Hospital, Yogyakarta.
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Table 1. The mean hospital stay ± SD for the survivors
Variabel Survivors Non-survivors p
Gender, n (%)
    
Man
 
Woman
 21
 
8
 3
 
0
 
 
0.55
Age (years ), mean ± 
SD
 42.41
 
± 13.44
 
57.33
 
± 14.43
 
0.2
 
20-46
 
years
 
47-76 years
 17
 
12
 0
 
3
 
 
0.092
At risk occupation, n 
(%) 
   
Yes 
No 
12 
17 
2  
1  
 
0.57
Rodent exposure, n 
(%) 
   
Yes
 No
 
21
 8
 
2
 1
 
 1
 Hemodialisis, n
    Yes
 No
 
10
 19
 
1
 2
 
 1
 ICU, n
    
Yes
No
4
25
2
1 0.083
The mean age ± SD for the survivors was 42.41 years ± 13.44 years, and for the non-survivors was 57.33 years 
± 14.43 years. In age variable there was no differences between the survivors and non survivors (p = 0.092)
The gender ratio between male and female patients with leptospirosis was  3:1, man 75% and women 
25%. There was no differences in gender between the survivors and non survivors (p = 0.55)
Table 2. Clinical sign and symptoms in survivors and non survivors among patients with Leptospirosis
Sign and 
symptoms
 Survivors
 
(n =
 
29
 
)
 
Non survivors
 
(n =
 
3
 
)
 
p
 
value
 
Fever
 
2
  
0
 
1.000
 
Dyspnea
 
15
 
2
 
1.000
 
Jaundice 19 3  0.534  
Cardiovascular 
collapse 
16 1  0.589  
Conjunctival 
Suffusion 
21 2  1.000  
Oliguria 9 3  0.044*  
Respiratory 
symptoms
 
7 2  0.184  
Neurological 
dysfunction
 
0
 
2
 
0.006*
 
Hemorragic 1 1 0.181
*statistically significant
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Table 3. Result of univariate analysis of laboratory values between survivors and non-survivors among 
patients with leptospirosis.
Value Survivors (n = 29) Nonsurvivors (n = 3)  p
Urea nitrogen  
(mg/dL)
 79.12 ± 43.14 139 ±  6.56  0.000*  
Creatinine (mg/dL)
 
6.17 ±
 
3.32
 
8.43 ±
 
3.75
 
0.275
 
Total protein (g/L)
 
5. 71 ±
 
0.69
 
5.6 ±
 
0.21
 
0.793
 
Albumin (g/L)
 
2.11 ±
 
0.46
 
1.61 ±
 
0.27
 
0.081
 
Total Bilirubun 
(mmol/L) 
7.76 ± 8.59
 
14.48 ± 4.78
 
0.099
 
Sodium (mmol/L) 125.9 ± 9.67 144.2 ±  15.77  0.027  
Potassium (mmol/L) 4.05 ± 0.81 5.29 ±  1.08  0.02*  
Chloride (mmol/L) 93.98 ± 10.23 100 ±  15.62  0.359  
Uric (mg/dL) 9.46 ± 3.66 11.5 ±  2.95  0.286  
AST (IU/L) 71 ± 46.2 123 ±  110.59  0.365  
ALT (IU/L) 53.58 ± 24.38 84.67 ±  48.44  0.064  
Glucose (mg/dL)
 
132.17 ±
 
72.02
 
115 ±
 
33.41
 
0.628
 WBC count  (109/L)
 
14.39 ±
 
5.29
 
13.74 ±
 
2.53
 
0.837
 Platelet 
 
count  
(109/L)
 
115.41 ±
 
87.05
 
76.67 ±
 
84.51
 
0.301
 
Hemoglobin (g/L)
 
11.84 ±
 
1.54
 
11.5 ±
 
0.26
 
0.305
 Hematocrit (%) 33.19 ± 4.59 32.5 ± 1.9 0.651
*statistically significant
Table 4. Result of multivariate stepwise logistic regression analysis of risk factors for patients with 
Leptospirosis.
Risk Factor
 
OR
 
95% CI
 
P value
 
Oliguria 0.75 0.541 –  1.04  0.018  
Urea nitrogen  
(mg/dL) 
0.813 0.642 -  1.028  0.025  
Potassium 
(mmol/L) 
10.8 1.194  –  97.728  0.009  
Neurological 
symptoms
 
30 4.367 –  206.07  0.000  
Discussion
In this study, several poor prognostic 
factors in leptospirosis have been identified, 
including higher admission serum potassium and 
neurological dysfunction (altered mentation or 
seizures) were associated with high in-hospital 
8fatality.  In another retrospective study, advanced 
age, oliguria, cardiac arrhythmia, dyspnea, and 
9pulmonary rales were associated with mortality.
Mortality in leptospirosis ranges from 1% 
1, 10, 11to 20 %.  In South India, a mortality of 5.32% 
was reported from Kolenchery and 3.5% from 
Madras. The study showed that there was no 
difference in mortality when patients were grouped 
by age, gender, at-risk occupation, or rodent 
exposure.
ARF occurs in 16% to 40% of leptospirosis 
and approximately 30% to 50% are non-oliguric, 
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10with a worse prognosis for oliguric renal failure.  
Ninety-seven percent of the patients had renal 
failure and all patients who died were oliguric. In 
our study, oliguria was a very sensitive criterion of 
the severity of the disease. Similarly, Seguro et al 
noted that the mortality rate for oliguric patients 
with acute renal failure were higher than that for 
patients with persistent dieresis. Again, 90% of 
leptospirosis is anicteric with a lower mortality 
compared with icteric forms. In our group, 68% of 
patients were icteric and there was no difference in 
mortality. 
Neurologic dysfunction (altered mentation 
or seizures) was the most significant predictor of 
mortality; most patients with neurologic 
dysfunction also had significant renal and hepatic 
disease contributing to encephalopathy. Altered 
mental status was the strongest independent 
predictor of death in urban leptospirosis in Brazil; 
other poor prognostic factors were oliguria, 
advanced age, renal and respiratory insufficiency. In 
this study, there was an association between altered 
12mental status and mortality.
Conclusions
The mortality of leptospirosis remains high 
despite improvements in patients care. In order to 
improve the early treatment of high-risk patients, 
these two clinically and two laboratory criteria, 
independently associated with mortality, could be 
used at the time of admission.
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